Adjuvant mRNA-4157 + Pembro in Melanoma
Phase II KEYNOTE-942: DMFS With Adjuvant mRNA-4157 (V940) + Pembrolizumab vs Pembrolizumab in Resected High-Risk Melanoma

Released: June 08, 2023

Activity

Progress
1
Course Completed